Nuveen Asset Management, LLC Affimed N.V. Transaction History

Nuveen Asset Management, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.66 - $1.29 $1,894 - $3,703	-2,871 Reduced 0.86%	332,053 $249,000
Q4 2022 Feb 14, 2023	SELL	$1.1 - $2.45 $22,851 - $50,896	-20,774 Reduced 5.84%	334,924 $415,000
Q3 2022 Nov 14, 2022	SELL	$1.96 - $3.32 $902,405 - $1.53 Million	-460,411 Reduced 56.42%	355,698 $733,000
Q2 2022 Aug 15, 2022	SELL	$2.27 - $4.86 $1.87 Million - $4 Million	-822,376 Reduced 50.19%	816,109 $2.26 Million
Q1 2022 May 16, 2022	BUY	$3.69 - $5.65 $412,209 - $631,161	111,710 Added 7.32%	1,638,485 $6.75 Million
Q4 2021 Feb 14, 2022	SELL	$5.37 - $7.07 $267,232 - $351,831	-49,764 Reduced 3.16%	1,526,775 $8.43 Million
Q3 2021 Nov 12, 2021	BUY	$5.54 - $7.51 $172,615 - $233,996	31,158 Added 2.02%	1,576,539 $9.74 Million
Q2 2021 Aug 16, 2021	BUY	$7.78 - $11.4 $1.7 Million - $2.49 Million	218,532 Added 16.47%	1,545,381 $13.1 Million
Q1 2021 May 17, 2021	BUY	$5.12 - $8.48 $681,763 - $1.13 Million	133,157 Added 11.16%	1,326,849 $10.5 Million
Q4 2020 May 17, 2021	BUY	$3.16 - $7.03 $504,800 - $1.12 Million	159,747 Added 15.45%	1,193,692 $6.95 Million
Q4 2020 Feb 16, 2021	BUY	$3.16 - $7.03 $430,436 - $957,584	136,214 Added 15.17%	1,033,945 $6.02 Million
Q3 2020 Nov 16, 2020	SELL	$3.26 - $4.73 $319,669 - $463,814	-98,058 Reduced 9.85%	897,731 $3.04 Million
Q2 2020 Aug 14, 2020	BUY	$1.58 - $4.63 $1.57 Million - $4.61 Million	995,789 New	995,789 $4.6 Million

1.09M

Ticker AFMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,339,008
Market Cap $185M
Description
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.